Quantitative Fluorescence Microscopy Provides High Resolution Imaging of Passive Diffusion and P-gp Mediated Efflux at the in Vivo Blood-brain Barrier
Overview
Affiliations
Quantitative fluorescent microscopy is an emerging technology that has provided significant insight into cellular dye accumulation, organelle function, and tissue physiology. However, historically dyes have only been used to qualitatively or semi-quantitatively (fold change) determine changes in blood-brain barrier (BBB) integrity. Herein, we present a novel method to calculate the blood to brain transfer rates of the dyes rhodamine 123 and Texas red across the in situ BBB. We observed that rhodamine 123 is subject to p-glycoprotein mediated efflux at the rat BBB and can be increased nearly 20-fold with p-glycoprotein inhibition. However, Texas Red appears to not be subject to MRP2 mediated efflux at the rat BBB, agreeing with literature reports suggesting MRP2 may lack functionality at the normal rat BBB. Lastly, we present data demonstrating that once dyes have crossed the BBB, diffusion of the dye molecule is not as instantaneous as has been previously suggested. We propose that future work can now be completed to (1) match BBB transfer coefficients to interstitial diffusion constants and (2) use dyes with specific affinities to cellular organelles or that have specific properties (e.g., subject to efflux transporters) to more fully understand BBB physiology.
Blethen K, Sprowls S, Arsiwala T, Wolford C, Panchal D, Fladeland R Radiat Oncol. 2023; 18(1):22.
PMID: 36732754 PMC: 9896731. DOI: 10.1186/s13014-023-02215-6.
Modulation of the blood-tumor barrier to enhance drug delivery and efficacy for brain metastases.
Blethen K, Arsiwala T, Fladeland R, Sprowls S, Panchal D, Adkins C Neurooncol Adv. 2021; 3(Suppl 5):v133-v143.
PMID: 34859240 PMC: 8633736. DOI: 10.1093/noajnl/vdab123.
Sprowls S, Saralkar P, Arsiwala T, Adkins C, Blethen K, Pizzuti V Pharmaceutics. 2021; 13(5).
PMID: 34069733 PMC: 8160855. DOI: 10.3390/pharmaceutics13050756.
Improving CNS Delivery to Brain Metastases by Blood-Tumor Barrier Disruption.
Sprowls S, Arsiwala T, Bumgarner J, Shah N, Lateef S, Kielkowski B Trends Cancer. 2019; 5(8):495-505.
PMID: 31421906 PMC: 6703178. DOI: 10.1016/j.trecan.2019.06.003.
Pogue B, Feng J, LaRochelle E, Bruza P, Lin H, Zhang R Nat Biomed Eng. 2019; 2(4):254-264.
PMID: 30899599 PMC: 6424530. DOI: 10.1038/s41551-018-0220-3.